Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1996;79:455-460

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ungerer, M.
Right arrow Articles by Richardt, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ungerer, M.
Right arrow Articles by Richardt, G.
(Circulation Research. 1996;79:455-460.)
© 1996 American Heart Association, Inc.


Articles

Activation of ß-Adrenergic Receptor Kinase During Myocardial Ischemia

Martin Ungerer, Kerstin Kessebohm, Kai Kronsbein, Martin J. Lohse, Gert Richardt

the 1. Medizinische Klinik der Technischen Universitat Munchen (M.U., K. Kessebohm,, K. Kronsbein, G.R.) and Pharmakologisches Institut der Universitat Wurzburg (M.J.L.) (Germany).

Correspondence to Dr Martin Ungerer, 1. Medizinische Klinik der Technischen Universitat Munchen, Klinikum rechts der Isar, Ismaningerstr 22, 81675 Munchen, Germany. E-mail ungerer@med1.med.tu-muenchen.de.

During myocardial ischemia, a local release of noradrenaline coincides with an increased density of ß-adrenergic receptors. The functional activity of these receptors, however, is mainly determined by their state of phosphorylation. The ß-adrenergic receptor kinase (ßARK) specifically phosphorylates and thereby inactivates ß-adrenergic receptors after stimulation by receptor agonists, facilitating the binding of the inhibitor protein ß-arrestin to the receptors. ßARK activation involves a translocation of the enzyme to the membrane. In the present study, we investigated the density and the functional activity of ß-adrenergic receptors, the enzymatic activity of ßARK in membranes and cytosol, the mRNA levels of ßARK-1, and the expression of ß-arrestin during stop-flow and low-flow ischemia in the isolated perfused rat heart. After 60 minutes of stop-flow ischemia, ß-adrenergic receptor density was upregulated, but ß-agonist–mediated adenylate cyclase activity was blunted. Simultaneously, ßARK activity in the particulate fraction was significantly induced. The increase in ßARK activity was reversible after inhibition of ischemia-evoked noradrenaline release by desipramine. Also, exposure to externally given noradrenaline increased ßARK activity in the particulate fraction. Cytosolic ßARK activity remained largely unchanged during stop-flow or low-flow ischemia. The steady state concentration of ßARK-1 mRNA increased after 20 minutes of stop-flow ischemia and then returned to baseline values after another 20 minutes. Cardiac ischemia did not alter ß-arrestin levels. During myocardial ischemia, an increase in the number of ß-adrenergic receptors is paralleled by increased membrane activity of the receptor kinase ßARK. This increased membrane activity may contribute to enhanced receptor phosphorylation and inactivation.


Key Words: ischemia • ß-adrenergic receptor kinase • rat heart




This article has been cited by other articles:


Home page
Circ. Res.Home page
A. Sabri, K. Rafiq, R. Seqqat, M. A. Kolpakov, R. Dillon, and L. J. Dell'italia
Sympathetic Activation Causes Focal Adhesion Signaling Alteration in Early Compensated Volume Overload Attributable to Isolated Mitral Regurgitation in the Dog
Circ. Res., May 9, 2008; 102(9): 1127 - 1136.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. J. Matkovich, A. Diwan, J. L. Klanke, D. J. Hammer, Y. Marreez, A. M. Odley, E. W. Brunskill, W. J. Koch, R. J. Schwartz, and G. W. Dorn II
Cardiac-Specific Ablation of G-Protein Receptor Kinase 2 Redefines Its Roles in Heart Development and {beta}-Adrenergic Signaling
Circ. Res., October 27, 2006; 99(9): 996 - 1003.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
P. Penela, C. Murga, C. Ribas, A. S. Tutor, S. Peregrin, and F. Mayor Jr.
Mechanisms of regulation of G protein-coupled receptor kinases (GRKs) and cardiovascular disease
Cardiovasc Res, January 1, 2006; 69(1): 46 - 56.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
X. Yu, S. Huang, E. Patterson, M. W. Garrett, K. M. Kaufman, J. P. Metcalf, M. Zhu, S. T. Dunn, and D. C. Kem
Proteasome degradation of GRK2 during ischemia and ventricular tachyarrhythmias in a canine model of myocardial infarction
Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H1960 - H1967.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Tachibana, S. V. Naga Prasad, R. J. Lefkowitz, W. J. Koch, and H. A. Rockman
Level of {beta}-Adrenergic Receptor Kinase 1 Inhibition Determines Degree of Cardiac Dysfunction After Chronic Pressure Overload-Induced Heart Failure
Circulation, February 8, 2005; 111(5): 591 - 597.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
J. V. Booth, E. E. Ward, K. C. Colgan, B. L. Funk, H. El-Moalem, M. P. Smith, C. Milano, P. K. Smith, M. F. Newman, and D. A. Schwinn
Metoprolol and Coronary Artery Bypass Grafting Surgery: Does Intraoperative Metoprolol Attenuate Acute {beta}-Adrenergic Receptor Desensitization During Cardiac Surgery?
Anesth. Analg., May 1, 2004; 98(5): 1224 - 1231.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
M. Momose, S. Reder, D. M. Raffel, P. Watzlowik, H.-J. Wester, N. Nguyen, P. H. Elsinga, F. M. Bengel, J. Remien, and M. Schwaiger
Evaluation of Cardiac {beta}-Adrenoreceptors in the Isolated Perfused Rat Heart Using (S)-11C-CGP12388
J. Nucl. Med., March 1, 2004; 45(3): 471 - 477.
[Abstract] [Full Text]


Home page
Mol. Interv.Home page
J. A. Hata and W. J. Koch
Phosphorylation of G Protein-Coupled Receptors: GPCR Kinases in Heart Disease
Mol. Interv., August 1, 2003; 3(5): 264 - 272.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. Makino, Y. Hattori, N. Matsuda, H. Onozuka, I. Sakuma, and A. Kitabatake
Effects of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Type 1 Receptor Blockade on beta -Adrenoceptor Signaling in Heart Failure Produced by Myocardial Infarction in Rabbits: Reversal of Altered Expression of beta -Adrenoceptor Kinase and Gialpha
J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 370 - 379.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. T. Tevaearai, A. D. Eckhart, K. F. Shotwell, K. Wilson, and W. J. Koch
Ventricular Dysfunction After Cardioplegic Arrest Is Improved After Myocardial Gene Transfer of a {beta}-Adrenergic Receptor Kinase Inhibitor
Circulation, October 23, 2001; 104(17): 2069 - 2074.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. Iaccarino, E. Barbato, E. Cipolleta, A. Esposito, A. Fiorillo, W. J. Koch, and B. Trimarco
Cardiac {beta}ARK1 Upregulation Induced by Chronic Salt Deprivation in Rats
Hypertension, August 1, 2001; 38(2): 255 - 260.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
V. Simon, S. Mhaouty-Kodja, C. Legrand, and J. Cohen-Tannoudji
Concomitant Increase of G Protein-Coupled Receptor Kinase Activity and Uncoupling of {beta}-Adrenergic Receptors in Rat Myometrium at Parturition
Endocrinology, May 1, 2001; 142(5): 1899 - 1905.
[Abstract] [Full Text]


Home page
CirculationHome page
A. S. Shah, D. C. White, S. Emani, A. P. Kypson, R. E. Lilly, K. Wilson, D. D. Glower, R. J. Lefkowitz, and W. J. Koch
In Vivo Ventricular Gene Delivery of a {beta}-Adrenergic Receptor Kinase Inhibitor to the Failing Heart Reverses Cardiac Dysfunction
Circulation, March 6, 2001; 103(9): 1311 - 1316.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. A. Gaballa, A. Eckhart, W. J. Koch, and S. Goldman
Vascular {beta}-adrenergic receptor system is dysfunctional after myocardial infarction
Am J Physiol Heart Circ Physiol, March 1, 2001; 280(3): H1129 - H1135.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. S. Lombardi, A. Kavelaars, P. M. Cobelens, R. E. Schmidt, M. Schedlowski, and C. J. Heijnen
Adjuvant Arthritis Induces Down-Regulation of G Protein-Coupled Receptor Kinases in the Immune System
J. Immunol., February 1, 2001; 166(3): 1635 - 1640.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
B. S. Manning, K. Shotwell, L. Mao, H. A. Rockman, and W. J. Koch
Physiological Induction of a {beta}-Adrenergic Receptor Kinase Inhibitor Transgene Preserves {beta}-Adrenergic Responsiveness in Pressure-Overload Cardiac Hypertrophy
Circulation, November 28, 2000; 102(22): 2751 - 2757.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
X. Yu, M. Zhang, K. Kyker, E. Patterson, J. L. Benovic, and D. C. Kem
Ischemic Inactivation of G Protein-Coupled Receptor Kinase and Altered Desensitization of Canine Cardiac {beta}-Adrenergic Receptors
Circulation, November 14, 2000; 102(20): 2535 - 2540.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Y. Xu, A. S. Clanachan, and B. I. Jugdutt
Enhanced Expression of Angiotensin II Type 2 Receptor, Inositol 1,4,5-Trisphosphate Receptor, and Protein Kinase C{epsilon} During Cardioprotection Induced by Angiotensin II Type 2 Receptor Blockade
Hypertension, October 1, 2000; 36(4): 506 - 510.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
A. S. Shah, D. C. White, O. Tai, J. A. Hata, K. H. Wilson, A. Pippen, A. P. Kypson, D. D. Glower, R. J. Lefkowitz, and W. J. Koch
Adenovirus-mediated genetic manipulation of the myocardial {beta}-adrenergic signaling system in transplanted hearts
J. Thorac. Cardiovasc. Surg., September 1, 2000; 120(3): 581 - 588.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Ramos-Ruiz, P. Penela, R. B. Penn, and F. Mayor Jr
Analysis of the Human G Protein-Coupled Receptor Kinase 2 (GRK2) Gene Promoter : Regulation by Signal Transduction Systems in Aortic Smooth Muscle Cells
Circulation, May 2, 2000; 101(17): 2083 - 2089.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
M. Ungerer, H.-J. Weig, S. Kubert, M. Overbeck, F. Bengel, A. Schomig, and M. Schwaiger
Regional pre- and postsynaptic sympathetic system in the failing human heart -- regulation of {beta}ARK-1
Eur J Heart Fail, March 1, 2000; 2(1): 23 - 31.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. F. M. van den Heuvel, D. J. van Veldhuisen, E. E. van der Wall, P. K. Blanksma, H.-M. J. Siebelink, W. M. Vaalburg, W. H. van Gilst, and H. J. G. M. Crijns
Regional myocardial blood flow reserve impairment and metabolic changes suggesting myocardial ischemia in patients with idiopathic dilated cardiomyopathy
J. Am. Coll. Cardiol., January 1, 2000; 35(1): 19 - 28.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. J. Liedtke and M. L. Lynch
Alteration of gene expression for glycolytic enzymes in aerobic and ischemic myocardium
Am J Physiol Heart Circ Physiol, October 1, 1999; 277(4): H1435 - H1440.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
N. Dzimiri
Regulation of beta -Adrenoceptor Signaling in Cardiac Function and Disease
Pharmacol. Rev., September 1, 1999; 51(3): 465 - 502.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Lochner, S. Genade, E. Tromp, T. Podzuweit, and J. A. Moolman
Ischemic Preconditioning and the {beta}-Adrenergic Signal Transduction Pathway
Circulation, August 31, 1999; 100(9): 958 - 966.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. A. Akhter, A. D. Eckhart, H. A. Rockman, K. Shotwell, R. J. Lefkowitz, and W. J. Koch
In Vivo Inhibition of Elevated Myocardial {beta}-Adrenergic Receptor Kinase Activity in Hybrid Transgenic Mice Restores Normal {beta}-Adrenergic Signaling and Function
Circulation, August 10, 1999; 100(6): 648 - 653.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. H. Strasser, G. Simonis, S. P. Schon, M. U. Braun, R. Ihl-Vahl, C. Weinbrenner, R. Marquetant, and W. Kubler
Two Distinct Mechanisms Mediate a Differential Regulation of Protein Kinase C Isozymes in Acute and Prolonged Myocardial Ischemia
Circ. Res., July 9, 1999; 85(1): 77 - 87.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
E. Carmeliet
Cardiac Ionic Currents and Acute Ischemia: From Channels to Arrhythmias
Physiol Rev, July 1, 1999; 79(3): 917 - 1017.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. P. Maurice, A. S. Shah, A. P. Kypson, J. A. Hata, D. C. White, D. D. Glower, and W. J. Koch
Molecular beta -adrenergic signaling abnormalities in failing rabbit hearts after infarction
Am J Physiol Heart Circ Physiol, June 1, 1999; 276(6): H1853 - H1860.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
M. Bunemann and M M. Hosey
G-protein coupled receptor kinases as modulators of G-protein signalling
J. Physiol., May 15, 1999; 517(1): 5 - 23.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. Iaccarino, P. C. Dolber, R. J. Lefkowitz, and W. J. Koch
ß-Adrenergic Receptor Kinase-1 Levels in Catecholamine-Induced Myocardial Hypertrophy : Regulation by ß- but not {alpha}1-Adrenergic Stimulation
Hypertension, January 1, 1999; 33(1): 396 - 401.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. Iaccarino, E. D. Tomhave, R. J. Lefkowitz, and W. J. Koch
Reciprocal In Vivo Regulation of Myocardial G Protein–Coupled Receptor Kinase Expression by ß-Adrenergic Receptor Stimulation and Blockade
Circulation, October 27, 1998; 98(17): 1783 - 1789.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. Iaccarino, H. A. Rockman, K. F. Shotwell, E. D. Tomhave, and W. J. Koch
Myocardial overexpression of GRK3 in transgenic mice: evidence for in vivo selectivity of GRKs
Am J Physiol Heart Circ Physiol, October 1, 1998; 275(4): H1298 - H1306.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. A. Rockman, D.-J. Choi, S. A. Akhter, M. Jaber, B. Giros, R. J. Lefkowitz, M. G. Caron, and W. J. Koch
Control of Myocardial Contractile Function by the Level of beta -Adrenergic Receptor Kinase 1 in Gene-targeted Mice
J. Biol. Chem., July 17, 1998; 273(29): 18180 - 18184.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Ishizaka, R. W. Alexander, J. B. Laursen, H. Kai, T. Fukui, M. Oppermann, R. J. Lefkowitz, P. R. Lyons, and K. K. Griendling
G Protein-coupled Receptor Kinase 5 in Cultured Vascular Smooth Muscle Cells and Rat Aorta. REGULATION BY ANGIOTENSIN II AND HYPERTENSION
J. Biol. Chem., December 19, 1997; 272(51): 32482 - 32488.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. A. Akhter, C. A. Skaer, A. P. Kypson, P. H. McDonald, K. C. Peppel, D. D. Glower, R. J. Lefkowitz, and W. J. Koch
Restoration of beta -adrenergic signaling in failing cardiac ventricular myocytes via adenoviral-mediated gene transfer
PNAS, October 28, 1997; 94(22): 12100 - 12105.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K.-L. Laugwitz, K. Kronsbein, M. Schmitt, K. Hoffmann, M. Seyfarth, A. Schomig, and M. Ungerer
Characterization and inhibition of {beta}-adrenergic receptor kinase in intact myocytes
Cardiovasc Res, August 1, 1997; 35(2): 324 - 333.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D.-J. Choi, W. J. Koch, J. J. Hunter, and H. A. Rockman
Mechanism of beta -Adrenergic Receptor Desensitization in Cardiac Hypertrophy Is Increased beta -Adrenergic Receptor Kinase
J. Biol. Chem., July 4, 1997; 272(27): 17223 - 17229.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. C. White, J. A. Hata, A. S. Shah, D. D. Glower, R. J. Lefkowitz, and W. J. Koch
Preservation of myocardial beta -adrenergic receptor signaling delays the development of heart failure after myocardial infarction
PNAS, May 9, 2000; 97(10): 5428 - 5433.
[Abstract] [Full Text] [PDF]